• $74.2M
    Market Cap
  • -16.92%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
09/30/2025
09/30/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-6.4M
+30.32%
-4.9M
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
23.5M
+14.34%
20.6M
+1,930.73%
1.0M
+633.50%
138,115
N/A
Operating Profit
-23.5M
+14.34%
-20.6M
+1,930.73%
-1.0M
+633.50%
-138,115
N/A
Interest Income
36,373
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-218,032
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
-181,659
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
-181,659
N/A
N/A
N/A
3.4M
+561.44%
518,926
N/A
Income before Taxes
-23.7M
+15.22%
-20.6M
+1,930.73%
-1.0M
+633.50%
-138,115
N/A
Income Taxes
1.1M
+83.50%
576,000
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-24.8M
+17.08%
-21.1M
-974.17%
2.4M
+535.30%
380,811
N/A
Net Income from Continuing Operations Applicable to Common
-23.7M
+15.22%
-20.6M
-950.36%
2.4M
+535.30%
380,811
N/A
Basic EPS and Net Income
-0.34
+9.68%
-0.31
-214.81%
0.27
+125.00%
0.12
N/A
Diluted EPS and Net Income
-0.34
+9.68%
-0.31
-214.81%
0.27
+125.00%
0.12
N/A
Basic Weighted Average Shares
73.3M
+7.66%
68.1M
+931.12%
6.6M
+253.80%
1.9M
N/A
Diluted Weighted Average Shares
73.3M
+7.66%
68.1M
+931.12%
6.6M
+391.89%
1.3M
N/A
Balance Sheet
Cash and Cash Equivalents
3.9M
+3,504,282.14%
112
-99.66%
32,746
-88.68%
289,175
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
3.9M
+3,504,282.14%
112
-99.66%
32,746
-88.68%
289,175
N/A
Total Current Assets
27.5M
+151.10%
11.0M
+18,746.87%
58,200
-84.58%
377,344
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
73.4M
0.00%
73.4M
N/A
0
N/A
0
N/A
Total Assets
100.9M
+19.64%
84.4M
+16.17%
72.6M
+6.50%
68.2M
N/A
Income Taxes Payable
2.8M
+61.17%
1.7M
+2,780.00%
60,000
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
3.8M
N/A
N/A
N/A
0
N/A
Total Current Liabilities
49.5M
+51.35%
32.7M
+1,498.45%
2.0M
+6,325.94%
31,836
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
1.3M
N/A
N/A
N/A
Total Long-Term Liabilities
5.6M
+61.17%
3.5M
N/A
N/A
N/A
N/A
N/A
Total Liabilities
56.1M
+46.69%
38.2M
+1,768.67%
2.0M
+6,325.94%
31,836
N/A
Retained Earnings
-64.0M
+63.04%
-39.3M
+1,876.05%
-2.0M
-675.71%
345,266
N/A
Total Stockholders Equity
44.9M
-2.76%
46.1M
+2,421.45%
-2.0M
-675.26%
345,508
N/A
Total Shares Outstanding
83.5M
+16.72%
71.6M
+2,956.49%
2.3M
-3.10%
2.4M
N/A
Cash Flow
Cash from Operating Activities
-5.5M
-4,446.59%
126,353
+121.01%
-601,304
+1,153.55%
-47,968
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-5.8M
+15.00%
-5.0M
+278.79%
-1.3M
-98.04%
-67.3M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
15.2M
+211.19%
4.9M
+192.74%
1.7M
-97.54%
67.7M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-26.72%
-0.81%
-26.94%
-884.08%
3.44%
N/A
N/A
N/A
Return on Equity
-54.42%
-43.20%
-95.80%
-67.49%
-294.67%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.56
+65.92%
0.34
+1,080.99%
0.03
N/A
N/A
N/A
Cash Ratio
0.08
N/A
0.00
-100.00%
0.02
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow